Navigation Links
Genelabs Technologies to Present at the Acumen Biofin Rodman & Renshaw 9th Annual Healthcare Conference
Date:11/5/2007

REDWOOD CITY, Calif., Nov. 5 /PRNewswire-FirstCall/ -- Genelabs Technologies, Inc. (Nasdaq: GNLB) announced today that the company will be webcasting its corporate presentation at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on Wednesday, November 7th at 8:50 am Eastern Time. The webcast can be accessed through the Investor Information section of the company's web site at http://www.Genelabs.com.

About Genelabs Technologies

Genelabs Technologies, Inc. is a biopharmaceutical company focused on the discovery and development of pharmaceutical products to improve human health. We have built drug discovery capabilities that can support various research and development projects. Genelabs is currently concentrating these capabilities on discovering novel compounds that selectively inhibit replication of the hepatitis C virus and advancing preclinical development of compounds from this hepatitis C virus drug discovery program, while also developing a late-stage product for lupus. We believe that these high-risk, potentially high reward programs focus our research and development expertise in areas where we have the opportunity to generate either first-in-class or best-in-class products that will address diseases for which current therapies are inadequate. For more information, please visit http://www.genelabs.com.

Note: Genelabs(R) and the Genelabs logo are registered trademarks of Genelabs Technologies, Inc.

Contact: James A. D. Smith

President and Chief Executive Officer

Phone: 650-562-1424


'/>"/>
SOURCE Genelabs Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Genelabs Technologies Announces Commitments to Raise $23.7 Million in a Registered Direct Financing
2. Genelabs Technologies Announces Completion of $23.7 Million Registered Direct Financing
3. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
4. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
5. VNUS Medical Technologies Announces Resignation of Chief Financial Officer and VP, Finance & Administration
6. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
7. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
8. Advanced technologies aim to transform the coaching of top athletes
9. Global Med Technologies(R) Extends Its Worldwide Outreach
10. Acuo Technologies(R) Names Mike Dolan Vice President of Sales
11. ReBuilder Medical Technologies, Inc. Signs Agreement for Distribution in Maine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... ... June 28, 2017 , ... ... recognized for excellence in employee engagement. Omaha-based C&A Industries, a national leader ... Most Engaged Workplaces™ in North America for 2017. The annual award, ...
(Date:6/28/2017)... , ... June 28, 2017 , ... Drs. Steven Crandall, ... TMJ, treatment in Pittsburgh, PA, and Upper St. Clair, PA, without a referral. The ... for restoring the health of the temporomandibular joint and facial muscles that support it. ...
(Date:6/28/2017)... (PRWEB) , ... June 28, 2017 , ... ... and consulting services, is proud to announce the guest speaker lineup* for its ... the National Alliance of Healthcare Purchaser Coalitions; Dr. Keith Fernandez of Privia Health; ...
(Date:6/28/2017)... ... 28, 2017 , ... Eating disorders have the highest mortality rate of any ... person dies as a direct result from an eating disorder in the U.S. As ... The iaedp Foundation meets this challenge by offering what has become the leading certification ...
(Date:6/28/2017)... ... June 28, 2017 , ... ... governance program for mid-market executives as a kick-off to the fifth annual CEO ... 24, 2017 on the University of Pennsylvania campus, followed by the two-day convention, ...
Breaking Medicine News(10 mins):
(Date:6/20/2017)... and LAGUNA HILLS, Calif. , ... of new data that validate the use of MMprofiler ... patients with multiple myeloma (MM). In a poster presentation ... Hematology Association (EHA) in Madrid, Spain ... MMprofiler for identifying high-risk elderly patients. ...
(Date:6/16/2017)... -- Exactly 50 years ago today, the Monterey Pop Festival opened ... the San Francisco "Summer of Love."  To celebrate the anniversary, ... in strategic market research portals that it will begin delivering ... Northern Light,s "Summer of Love (For Our Customers)."  ... ...
(Date:6/13/2017)... WARSAW, Ind. , June 13, 2017 Zimmer ... in musculoskeletal healthcare, today announced that the U.S. Food and ... Letter dated June 3, 2015 relating to its ... "The successful clearance of ... China manufacturing facility is a measure of the ...
Breaking Medicine Technology: